154 related articles for article (PubMed ID: 24674587)
1. Prophylactic effects of the glucagon-like Peptide-1 analog liraglutide on hyperglycemia in a rat model of type 2 diabetes mellitus associated with chronic pancreatitis and obesity.
Nagakubo D; Shirai M; Nakamura Y; Kaji N; Arisato C; Watanabe S; Takasugi A; Asai F
Comp Med; 2014 Apr; 64(2):121-7. PubMed ID: 24674587
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist.
Namekawa J; Nemoto S; Sunada G; Takanashi Y; Fujio S; Shirai M; Asai F
J Vet Med Sci; 2018 Oct; 80(10):1515-1523. PubMed ID: 30175725
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats.
Cummings BP; Stanhope KL; Graham JL; Baskin DG; Griffen SC; Nilsson C; Sams A; Knudsen LB; Raun K; Havel PJ
Diabetes; 2010 Oct; 59(10):2653-61. PubMed ID: 20622169
[TBL] [Abstract][Full Text] [Related]
4. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
5. Plasma profiles of glucose, insulin and lipids in the male WBN/Kob-Lepr(fa) rat, a new model of type 2 diabetes with obesity.
Kaji N; Okuno A; Ohno-Ichiki K; Oki H; Ishizawa H; Shirai M; Asai F
J Vet Med Sci; 2012 Sep; 74(9):1185-9. PubMed ID: 22571894
[TBL] [Abstract][Full Text] [Related]
6. One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
Degn KB; Juhl CB; Sturis J; Jakobsen G; Brock B; Chandramouli V; Rungby J; Landau BR; Schmitz O
Diabetes; 2004 May; 53(5):1187-94. PubMed ID: 15111485
[TBL] [Abstract][Full Text] [Related]
7. Effects of liraglutide on metabolic syndrome in WBN/Kob diabetic fatty rats supplemented with a high-fat diet.
Kaji N; Takagi Y; Matsuda S; Takahashi A; Fujio S; Asai F
Animal Model Exp Med; 2020 Mar; 3(1):62-68. PubMed ID: 32318661
[TBL] [Abstract][Full Text] [Related]
8. Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Coma M; Cano-Sarabia M; Vázquez F; Verdaguer J; Vives-Pi M
Front Endocrinol (Lausanne); 2020; 11():258. PubMed ID: 32477262
[TBL] [Abstract][Full Text] [Related]
9. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.
Hansen G; Jelsing J; Vrang N
Acta Pharmacol Sin; 2012 Feb; 33(2):194-200. PubMed ID: 22301859
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide prevents diabetes progression in prediabetic OLETF rats.
Guo N; Sun J; Chen H; Zhang H; Zhang Z; Cai D
Endocr J; 2013; 60(1):15-28. PubMed ID: 22986487
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not.
Raun K; von Voss P; Gotfredsen CF; Golozoubova V; Rolin B; Knudsen LB
Diabetes; 2007 Jan; 56(1):8-15. PubMed ID: 17192459
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T; Christensen M; Junker AE; Knop FK; Gluud LL
BMJ; 2012 Jan; 344():d7771. PubMed ID: 22236411
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus.
Vedtofte L; Bodvarsdottir TB; Gotfredsen CF; Karlsen AE; Knudsen LB; Heller RS
Regul Pept; 2010 Feb; 160(1-3):106-14. PubMed ID: 20005262
[TBL] [Abstract][Full Text] [Related]
15. Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.
Trevaskis JL; Sacramento CB; Jouihan H; Ali S; Le Lay J; Oldham S; Bhagroo N; Boland BB; Cann J; Chang Y; O'Day T; Howard V; Reers C; Winzell MS; Smith DM; Feigh M; Barkholt P; Schreiter K; Austen M; Andag U; Thompson S; Jermutus L; Coghlan MP; Grimsby J; Dohrmann C; Rhodes CJ; Rondinone CM; Sharma A
Diabetes; 2017 Jul; 66(7):2007-2018. PubMed ID: 28408435
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of the glucagon-like peptide-1 analog liraglutide in healthy cats.
Hall MJ; Adin CA; Borin-Crivellenti S; Rudinsky AJ; Rajala-Schultz P; Lakritz J; Gilor C
Domest Anim Endocrinol; 2015 Apr; 51():114-21. PubMed ID: 25625650
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide suppresses obesity and hyperglycemia associated with increases in hepatic fibroblast growth factor 21 production in KKAy mice.
Nonogaki K; Hazama M; Satoh N
Biomed Res Int; 2014; 2014():751930. PubMed ID: 24804243
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
[TBL] [Abstract][Full Text] [Related]
19. Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet.
Sakai T; Kusakabe T; Ebihara K; Aotani D; Yamamoto-Kataoka S; Zhao M; Gumbilai VM; Ebihara C; Aizawa-Abe M; Yamamoto Y; Noguchi M; Fujikura J; Hosoda K; Inagaki N; Nakao K
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E712-9. PubMed ID: 25159327
[TBL] [Abstract][Full Text] [Related]
20. Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats.
Wu L; Olverling A; Fransson L; Ortsäter H; Kappe C; Gao X; Sjöholm A
Regul Pept; 2012 Aug; 177(1-3):92-6. PubMed ID: 22587909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
